Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Bioorg Chem ; 107: 104525, 2021 02.
Article in English | MEDLINE | ID: mdl-33317840

ABSTRACT

Hunting small molecules as anti-inflammatory agents/drugs is an expanding and successful approach to treat several inflammatory diseases such as cancer, asthma, arthritis, and psoriasis. Besides other methods, inflammatory diseases can be treated by lipoxygenase inhibitors, which have a profound influence on the development and progression of inflammation. In the present study, a series of new N-alkyl/aralky/aryl derivatives (7a-o) of 2-(4-phenyl-5-(1-phenylcarbamoyl)piperidine-4H-1,2,4-triazol-3-ylthio)acetamide was synthesized and screened for their inhibitory potential against the enzyme 15-lipoxygenase. The simple precursor ethyl piperidine-4-carboxylate (a) was successively converted into phenylcarbamoyl derivative (1), hydrazide (2), semicarbazide (3) and N-phenylated 5-(1-phenylcarbamoyl)piperidine-1,2,4-triazole (4), then in combination with electrophiles (6a-o) through further multistep synthesis, final products (7a-o) were generated. All the synthesized compounds were characterized by FTIR, 1H, 13C NMR spectroscopy, EIMS, and HREIMS spectrometry. Almost all the synthesized compounds showed excellent inhibitory potential against the tested enzyme. Compounds 7c, 7f, 7d, and 7g displayed potent inhibitory potential (IC50 9.25 ± 0.26 to 21.82 ± 0.35 µM), followed by the compounds 7n, 7h, 7e, 7a, 7b, 7l, and 7o with IC50 values in the range of 24.56 ± 0.45 to 46.91 ± 0.57 µM. Compounds 7c, 7f, 7d exhibited 71.5 to 83.5% cellular viability by MTT assay compared with standard curcumin (76.9%) when assayed at 0.125 mM concentration. In silico ADME studies supported the drug-likeness of most of the molecules. In vitro inhibition studies were substantiated by molecular docking wherein the phenyl group attached to the triazole ring was making a π-δ interaction with Leu607. This work reveals the possibility of a synthetic approach of compounds in relation to lipoxygenase inhibition as potential lead compounds in drug discovery.


Subject(s)
Acetanilides/pharmacology , Lipoxygenase Inhibitors/pharmacology , Triazoles/pharmacology , Acetanilides/chemical synthesis , Acetanilides/metabolism , Acetanilides/pharmacokinetics , Arachidonate 15-Lipoxygenase/metabolism , Humans , Hydrogen Bonding , Lipoxygenase Inhibitors/chemical synthesis , Lipoxygenase Inhibitors/metabolism , Lipoxygenase Inhibitors/pharmacokinetics , Molecular Docking Simulation , Molecular Structure , Protein Binding , Soybean Proteins/antagonists & inhibitors , Soybean Proteins/metabolism , Glycine max/enzymology , Static Electricity , Structure-Activity Relationship , Triazoles/chemical synthesis , Triazoles/metabolism , Triazoles/pharmacokinetics
2.
Molecules ; 23(10)2018 Sep 30.
Article in English | MEDLINE | ID: mdl-30274341

ABSTRACT

A new series of 2,4,6-trihydroxy-3-geranyl-acetophenone (tHGA) analogues were synthesized and evaluated for their lipoxygenase (LOX) inhibitory activity. Prenylated analogues 4a⁻g (half maximal inhibitory concentration (IC50) values ranging from 35 µ M to 95 µ M) did not exhibit better inhibitory activity than tHGA (3a) (IC50 value: 23.6 µ M) due to the reduction in hydrophobic interaction when the alkyl chain length was reduced. One geranylated analogue, 3d, with an IC50 value of 15.3 µ M, exhibited better LOX inhibitory activity when compared to tHGA (3a), which was in agreement with our previous findings. Kinetics study showed that the most active analogue (3e) and tHGA (3a) acted as competitive inhibitors. The combination of in silico approaches of molecular docking and molecular dynamic simulation revealed that the lipophilic nature of these analogues further enhanced the LOX inhibitory activity. Based on absorption, distribution, metabolism, excretion, and toxicity (ADMET) and toxicity prediction by komputer assisted technology (TOPKAT) analyses, all geranylated analogues (3a⁻g) showed no hepatotoxicity effect and were biodegradable, which indicated that they could be potentially safe drugs for treating inflammation.


Subject(s)
Acetophenones , Glycine max/enzymology , Lipoxygenase Inhibitors , Lipoxygenase/chemistry , Soybean Proteins , Acetophenones/chemical synthesis , Acetophenones/chemistry , Lipoxygenase Inhibitors/chemical synthesis , Lipoxygenase Inhibitors/chemistry , Soybean Proteins/antagonists & inhibitors , Soybean Proteins/chemistry , Structure-Activity Relationship
3.
Molecules ; 22(8)2017 Jul 25.
Article in English | MEDLINE | ID: mdl-28757554

ABSTRACT

Our research to discover potential new multitarget agents led to the synthesis of 10 novel derivatives of cinnamic acids and propranolol, atenolol, 1-adamantanol, naphth-1-ol, and (benzylamino) ethan-1-ol. The synthesized molecules were evaluated as trypsin, lipoxygenase and lipid peroxidation inhibitors and for their cytotoxicity. Compound 2b derived from phenoxyphenyl cinnamic acid and propranolol showed the highest lipoxygenase (LOX) inhibition (IC50 = 6 µΜ) and antiproteolytic activity (IC50 = 0.425 µΜ). The conjugate 1a of simple cinnamic acid with propranolol showed the higher antiproteolytic activity (IC50 = 0.315 µΜ) and good LOX inhibitory activity (IC50 = 66 µΜ). Compounds 3a and 3b, derived from methoxylated caffeic acid present a promising combination of in vitro inhibitory and antioxidative activities. The S isomer of 2b also presented an interesting multitarget biological profile in vitro. Molecular docking studies point to the fact that the theoretical results for LOX-inhibitor binding are identical to those from preliminary in vitro study.


Subject(s)
Cinnamates , Lipoxygenase Inhibitors , Lipoxygenase/chemistry , Propranolol , Protease Inhibitors , Soybean Proteins , Animals , Cell Line , Cinnamates/chemical synthesis , Cinnamates/chemistry , Lipoxygenase Inhibitors/chemical synthesis , Lipoxygenase Inhibitors/chemistry , Mice , Propranolol/analogs & derivatives , Propranolol/chemical synthesis , Propranolol/chemistry , Protease Inhibitors/chemical synthesis , Protease Inhibitors/chemistry , Soybean Proteins/antagonists & inhibitors , Soybean Proteins/chemistry , Glycine max
4.
Biosci Biotechnol Biochem ; 80(10): 1973-9, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27033966

ABSTRACT

Gly m Bd 28K is one of the major allergens in soybeans, but there is limited information on its IgG-binding epitopes. Thirty-four overlapping peptides that covered the entire sequence of Gly m Bd 28K were synthesized, and 3 monoclonal antibodies against Gly m Bd 28K were utilized to identify the IgG-binding regions of Gly m Bd 28K. Three dominant peptides corresponding to (28)GDKKSPKSLFLMSNS(42)(G28-S42), (56)LKSHGGRIFYRHMHI(70)(L56-I70), and (154)ETFQSFYIGGGANSH(168)(E154-H168) were recognized. L56-I70 is the most important epitope, and a competitive ELISA indicated that it could inhibit the binding of monoclonal antibody to Gly m Bd 28K protein. Alanine scanning of L56-I70 documented that F64, Y65, and R66 were the critical amino acids of this epitope. Two bioinformatics tools, ABCpred and BepiPred, were used to predict the epitopes of Gly m Bd 28K, and the predictions were compared with the epitopes that we had located by monoclonal antibodies.


Subject(s)
Antigens, Plant/chemistry , Antigens, Plant/immunology , Epitope Mapping , Glycoproteins/chemistry , Glycoproteins/immunology , Immunoglobulin G/immunology , Soybean Proteins/chemistry , Soybean Proteins/immunology , Amino Acid Sequence , Animals , Antigens, Plant/metabolism , Computational Biology , Glycoproteins/antagonists & inhibitors , Glycoproteins/metabolism , Mice , Peptides/chemistry , Peptides/pharmacology , Soybean Proteins/antagonists & inhibitors , Soybean Proteins/metabolism
5.
Nat Prod Commun ; 10(5): 743-6, 2015 May.
Article in English | MEDLINE | ID: mdl-26058148

ABSTRACT

The phytotoxic effect of the allelochemical cyanamide has been well-documented yet the underlying mechanism for this phenomenon has not been fully characterized. Cognizant of the putative inhibitory effect of cyanamide on aldehyde dehydrogenases (ALDHs), we hereby show that the capacity of mitochondrial preparations from cyanamide-treated soybean seedlings to oxidize acetaldehyde and succinic-semialdehyde was dose-dependently reduced to at most 55% and 70%, respectively. Cyanamide-treated plants exhibited oxidative stress (i.e. increased lipid peroxidation and H2O2 accumulation) that was exacerbated upon exposure to UV-A--symptoms reminiscent of ALDH and succinic-semialdehyde dehydrogenase (SSADH) knock-out Arabidopsis mutants. We suggest that the inhibition of mitochondrial ALDH and SSADH may be a contributory mechanism to the burst in oxidative stress mediated by cyanamide.


Subject(s)
Aldehyde Dehydrogenase/antagonists & inhibitors , Cyanamide/toxicity , Enzyme Inhibitors/pharmacology , Glycine max/drug effects , Oxidative Stress/drug effects , Soybean Proteins/antagonists & inhibitors , Aldehyde Dehydrogenase/genetics , Aldehyde Dehydrogenase/metabolism , Hydrogen Peroxide/metabolism , Lipid Peroxidation/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Pheromones/toxicity , Seedlings/drug effects , Seedlings/enzymology , Seedlings/genetics , Seedlings/metabolism , Soybean Proteins/genetics , Soybean Proteins/metabolism , Glycine max/enzymology , Glycine max/genetics , Glycine max/metabolism
6.
J Sci Food Agric ; 93(12): 2927-32, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23426933

ABSTRACT

BACKGROUND: Glycinin is a seed storage protein in soybean (Glycine max) that is allergenic in pigs. Glycinin is a hexamer composed of subunits consisting of basic and acidic portions joined by disulfide bridges. There are five glycinin subunit isoforms designated Gy1-Gy5. The purpose of this study is to identify epitopes from selected glycinin subunits that are antigenic in pigs. RESULTS: Twenty-seven out of 30 pigs had antibodies against glycinin in their sera. Ten of these sera had immunoglobulin G (IgG) against the Gy4 (A5A4B3) or Gy1 (A1aBx) subunit. Three sera recognised overlapping regions between the two subunits tested, though no serum stained both A5A4B3 and A1aBx. Two sera stained a highly conserved region between A5A4B3 and A1aBx, though again neither serum stained both peptides. The basic part of the A1aBx subunit was not recognised by any of the sera tested even though immunoblot data indicated that the basic and acidic subunits of glycinin are nearly equally antigenic. CONCLUSION: Two antigenic regions of A5A4B3 and A1aBx were identified that bound antibodies in half of the sera that reacted with these two proteins. Half of the sera reacted with unique regions of A5A4B3 and A1aBx. The failure of the basic portion of A1aBx to bind pig antibodies may indicate that it is less antigenic than the basic portion of A5A4B3 and other glycinin subunits.


Subject(s)
Antigens, Plant/analysis , Dietary Proteins/antagonists & inhibitors , Epitopes/analysis , Food Hypersensitivity/veterinary , Globulins/antagonists & inhibitors , Seed Storage Proteins/antagonists & inhibitors , Soybean Proteins/antagonists & inhibitors , Swine Diseases/immunology , Amino Acid Sequence , Animals , Antigens, Plant/adverse effects , Antigens, Plant/chemistry , Conserved Sequence , Cross Reactions , Crosses, Genetic , Dietary Proteins/adverse effects , Dietary Proteins/chemistry , Epitope Mapping/veterinary , Female , Food Hypersensitivity/blood , Food Hypersensitivity/etiology , Food Hypersensitivity/immunology , Globulins/adverse effects , Globulins/chemistry , Lactation , Pregnancy , Pregnancy Complications/blood , Pregnancy Complications/etiology , Pregnancy Complications/immunology , Pregnancy Complications/veterinary , Protein Subunits/adverse effects , Protein Subunits/antagonists & inhibitors , Protein Subunits/chemistry , Seed Storage Proteins/adverse effects , Seed Storage Proteins/chemistry , Soybean Proteins/adverse effects , Soybean Proteins/chemistry , Glycine max/adverse effects , Sus scrofa , Swine , Swine Diseases/blood , Swine Diseases/etiology , United States
7.
Eur J Med Chem ; 57: 134-42, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23047230

ABSTRACT

All of the mono isopentenyloxy, -geranyloxy and -farnesyloxy derivatives of coumarin were synthesized and their inhibitory potency against soybean 15-lipoxygenase (SLO) and human 15-lipoxygenase-1 (HLO-1) were determined. Amongst the synthetic analogs, 5-farnesyloxycoumarin showed the most potent inhibitory activity against SLO (IC(50) = 0.8 µM) while 6-farnesyloxycoumarin was the strongest HLO-1 inhibitor (IC(50) = 1.3 µM). The IC(50) variations of the farnesyl derivatives for HLO-1 (1.3 to ∼75 µM) were much higher than that observed for SLO (0.8-5.8 µM). SAR studies showed that hydrogen bonding, CH/π, anion-π and S-OC interactions with Fe(III)-OH, Leu408, Glu357 and Met419 were the distinct intermolecular interactions which can lead to important role of the coumarin substitution site in HLO-1 inhibitory potency, respectively.


Subject(s)
Arachidonate 15-Lipoxygenase/chemistry , Coumarins/chemical synthesis , Lipoxygenase Inhibitors/chemical synthesis , Soybean Proteins/chemistry , Coumarins/chemistry , Humans , Hydrogen Bonding , Kinetics , Lipoxygenase Inhibitors/chemistry , Molecular Docking Simulation , Protein Prenylation , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/chemistry , Soybean Proteins/antagonists & inhibitors , Glycine max/chemistry , Glycine max/enzymology , Structure-Activity Relationship
8.
J Food Sci ; 77(6): C603-8, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22591269

ABSTRACT

UNLABELLED: With the widespread use of Roundup Ready soy (event 40-3-2) (RRS), the comprehensive detection of genetically modified component in foodstuffs is of significant interest, but few protein-based approaches have been found useful in processed foods. In this report, the combination of quantitative PCR (qPCR) and western blot was used to detect cp4-epsps gene and its protein product in different RRS plant tissues and commercial soy-containing foodstuffs. The foods included those of plant origin produced by different processing procedures and also some products containing both meat and plant protein concentrates. The validity of the 2 methods was confirmed first. We also showed that the CP4-EPSPS protein existed in different RRS plant tissues. In certain cases, the results from the western blot and the qPCR were not consistent. To be specific, at least 2 degraded fragments of CP4-EPSPS protein (35.5 and 24.6 kDa) were observed. For dried bean curd crust and deep-fried bean curd, a degraded protein fragment with the size of 24.6 kDa appeared, while cp4-epsps gene could not be traced by qPCR. In contrast, we found a signal of cp4-epsps DNA in 3 foodstuffs, including soy-containing ham cutlet product, meat ball, and sausage by qPCR, while CP4-EPSPS protein could not be detected by western blot in such samples. Our study therefore concluded that the combination of DNA- and protein-based methods would compensate each other, thus resulting in a more comprehensive detection from nucleic acid and protein levels. PRACTICAL APPLICATION: The combination of quantitative PCR (qPCR) and western blot was used to detect cp4-epsps gene and its protein product in different Roundup Ready soy (event 40-3-2) plant tissues and commercial soy-containing foodstuffs. The foods included those of plant origin produced by different processing procedures and also some products containing a combination of both meat and plant protein concentrates. This study indicated that the combination of DNA- and protein-based methods would supplement each other for genetically modified detection from nucleic acid and protein levels. Accordingly, qPCR and western blot could be used in CP4-EPSPS detection in a wide variety of soy-related foodstuffs.


Subject(s)
3-Phosphoshikimate 1-Carboxyvinyltransferase/metabolism , Food Inspection/methods , Food, Genetically Modified , Glycine max/metabolism , Plants, Genetically Modified/metabolism , Soy Foods/analysis , Soybean Proteins/metabolism , 3-Phosphoshikimate 1-Carboxyvinyltransferase/antagonists & inhibitors , 3-Phosphoshikimate 1-Carboxyvinyltransferase/chemistry , 3-Phosphoshikimate 1-Carboxyvinyltransferase/genetics , Agrobacterium/genetics , Agrobacterium/metabolism , Blotting, Western , China , DNA, Plant/isolation & purification , DNA, Plant/metabolism , Drug Resistance/genetics , Enzyme Inhibitors/pharmacology , Genes, Bacterial , Glycine/analogs & derivatives , Glycine/pharmacology , Herbicides/pharmacology , Meat Products/analysis , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Plants, Genetically Modified/drug effects , Real-Time Polymerase Chain Reaction , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Soybean Proteins/antagonists & inhibitors , Soybean Proteins/chemistry , Soybean Proteins/genetics , Glycine max/drug effects , Glycine max/genetics , Glyphosate
9.
J Food Sci ; 77(1): H9-15, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22260109

ABSTRACT

UNLABELLED: Pineapple stem has been extensively used for bromelain extraction; however, almost no attention has been given to the waste obtained during bromelain manufacturing. In this regard, antioxidant, antimicrobial, and inhibitions against 15-lipoxygenase and advanced glycation end product formations by pineapple stem waste (PSW) obtained during bromelain manufacturing process were studied. The PSW had moderate bioactivities in all the performed assays. It also showed a considerable inhibition against fungal growth, probably due to high amounts of the benzoic acid present in the sample. These results indicate that PSW could be utilized as an economic source of preventive or therapeutic agent in disease and in different functional food industries. PRACTICAL APPLICATION: A large amount of wastes are generated during bromelain manufacturing from pineapple stem. So far, these wastes are not utilized and are often considered as a burden while disposing them. However, we found some important phytochemicals with considerable bioactivities in these wastes. We believe that these wastes may have a promising usage as a cheap source of one of the ingredients in functional food based industries.


Subject(s)
Ananas/chemistry , Anti-Infective Agents/pharmacology , Antioxidants/pharmacology , Glycation End Products, Advanced/antagonists & inhibitors , Industrial Waste/analysis , Lipoxygenase Inhibitors/pharmacology , Plant Stems/chemistry , Anti-Bacterial Agents/economics , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/chemistry , Anti-Infective Agents/economics , Antifungal Agents/economics , Antifungal Agents/pharmacology , Antioxidants/chemistry , Antioxidants/economics , Arachidonate 15-Lipoxygenase/chemistry , Colletotrichum/drug effects , Disk Diffusion Antimicrobial Tests , Drug Discovery , Drug Industry/economics , Food-Processing Industry/economics , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Industrial Waste/economics , Japan , Lipoxygenase Inhibitors/chemistry , Lipoxygenase Inhibitors/economics , Phenols/chemistry , Phenols/economics , Phenols/pharmacology , Soybean Proteins/antagonists & inhibitors
10.
Article in Portuguese | LILACS | ID: lil-552749

ABSTRACT

O papel específico das modificações da dieta no tratamento da nefropatia diabética (ND) ainda não está elucidado. A substituição de proteína de origem animal por soja em pacientes com Diabete Melito (DM) poderia ser benéfica para a função renal. O objetivo do presente manuscrito foi revisar criticamente as evidências acerca do papel da soja na ND. Foram selecionados seis ensaios clínicos randomizados conduzidos em pacientes com DM, dentre os quais cinco demonstraram melhora de pelo menos um marcador de função renal com a dieta com soja. Os mecanismos através dos quais essas dietas promoveriam melhora da ND não foram elucidados, assim como não está estabelecido ainda se há distinção no efeito benéfico aos rins dos diferentes produtos à base de soja disponíveis no mercado. Novos estudos são necessários para que tais questões possam ser elucidadas e para que os benefícios da soja na ND possam ser confirmados.


The specific role of dietary changes in the treatment of diabetic nephropathy (DN) has not yet been elucidated. The animal source protein replacement for soy in patients with Diabetes Mellitus (DM) may provide potential benefits for renal function. The aim of the present manuscript was to perform a critical review of evidence about the role of soy in DN. Six randomized clinical trials conducted in patients with DM were selected, and five of them showed improvement of at least one marker of renal function with the soy diet. However, the mechanisms by which these diets promote improvement in DN have not been elucidated. It is not yet known whether there are distinguishable renal benefits ensured by different soy-based products available on the market. Further studies are needed to clarify theses aspects and to confirm the benefits of soy in DN.


Subject(s)
Humans , Male , Female , Diet/methods , Diet/trends , Diet , Diabetic Nephropathies/complications , Diabetic Nephropathies/diagnosis , Diabetic Nephropathies/epidemiology , Diabetic Nephropathies/pathology , Diabetic Nephropathies/therapy , Renal Insufficiency, Chronic , Soy Foods , Diabetes Mellitus , Randomized Controlled Trials as Topic/statistics & numerical data , Randomized Controlled Trials as Topic/standards , Randomized Controlled Trials as Topic/trends , Randomized Controlled Trials as Topic , Soybean Proteins/antagonists & inhibitors , Soybean Proteins , Soybean Proteins/therapeutic use , Plant Proteins, Dietary
11.
Horm Metab Res ; 39(1): 14-9, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17226108

ABSTRACT

Inositol phosphoglycan-like compounds are produced by the hydrolysis of the membrane bound glycosyl phosphoinositides. Besides being short term mediators of insulin action, they inhibit peroxidases and catalase, increasing the concentration of cellular hydrogen peroxide. Although high concentrations of hydrogen peroxide are toxic, moderate increases of its basal level are signals for different metabolic pathways. The inhibitor, localized in the cytosol of the cell, acts on peroxidases and catalase of the same tissue (homologous action) and of other tissues or organisms (heterologous action). The inositol phosphoglycan-like compound inhibits peroxidases with different prosthetic groups, i.e. containing iron such as: thyroid peroxidase, lactoperoxidase, horseradish peroxidase, soy bean peroxidase; and containing selenium such as glutathione peroxidase and 2-cys peroxiredoxin with no prosthetic group. Besides peroxidases, the inositol phosphoglycan-like compound inhibits catalase, another heme enzyme. The inhibition kinetics demonstrates a noncompetitive effect. The site of action is not the prosthetic group, given that the inhibitor does not produce any effect on the peak in the Soret region in the presence or absence of hydrogen peroxide. In conclusion, the inositol phosphoglycan-like compound is the general inhibitor of peroxidases and catalase involved in the modulation of hydrogen peroxide level that acts in different metabolic pathways as a signal transducer.


Subject(s)
Catalase/antagonists & inhibitors , Hydrogen Peroxide/metabolism , Inositol Phosphates/pharmacology , Peroxidase/antagonists & inhibitors , Polysaccharides/pharmacology , Animals , Cattle , Cells, Cultured , Enzyme Inhibitors/pharmacology , Horseradish Peroxidase/antagonists & inhibitors , Iodide Peroxidase/antagonists & inhibitors , Lactoperoxidase/antagonists & inhibitors , Soybean Proteins/antagonists & inhibitors , Glycine max/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...